Literature DB >> 2831873

Stress and the pituitary-adrenal axis.

R C Gaillard, S Al-Damluji.   

Abstract

The hypothalamo-pituitary-adrenal axis is controlled by complex regulatory mechanisms. Numerous factors such as CRF, vasopressin, oxytocin, angiotensin II and conceivably other hormones--all controlled by various substances acting on central locations--stimulate the release of the stress hormone ACTH. On the other hand, glucocorticoids inhibit the secretion of ACTH by acting at the hypothalamic and/or pituitary level. The release of ACTH is therefore the final outcome of the interactions between the hypothalamus, the adrenal gland and possibly other organs. The multimolecular nature of the factors responsible for the control of the pituitary-adrenal axis is an attractive hypothesis because of the great variety of stress stimuli. The various factors could have specific roles in various stress situations. They provide a highly sensitive mechanism regulating very finely the stress hormone in response to a whole variety of endogenous and exogenous stimuli. Depending on the type of stress, they may therefore singly or in combination affect the amount and duration of ACTH and steroid secretion. The released glucocorticoids may then produce their numerous effects on inflammatory and immunological processes, carbohydrate metabolism, shock and water balance. It has been postulated that these effects may be important in order to prevent host responses from over-reacting to stress and threatening homeostasis. However, proof of the necessity of the glucocorticoid hypersecretion in response to stress remains elusive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2831873     DOI: 10.1016/s0950-351x(87)80066-6

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  8 in total

1.  Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.

Authors:  S Grottoli; B Maccagno; J Ramunni; L Di Vito; R Giordano; L Gianotti; S DeStefanis; F Camanni; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

2.  The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic--pituitary--adrenal (HPA) axis in humans.

Authors:  Ioannis Karamouzis; Rita Berardelli; Elisa Marinazzo; Valentina D'Angelo; Domenico Zinnà; Marco Alessandro Minetto; Clizia Zichi; Beatrice Fussotto; Roberta Giordano; Ezio Ghigo; Emanuela Arvat
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

3.  Effects of chronic immobilization stress on biokinetics and dosimetry of 67Ga in a murine model.

Authors:  Jorge Ramírez-Franco; Rigoberto Oros-Pantoja; Eugenio Torres-García; Liliana Aranda-Lara; Luis E Díaz-Sánchez; Claudia I Herrera-Ayala; Elvia Pérez-Soto; Erika P Azorín-Vega
Journal:  Radiat Environ Biophys       Date:  2020-04-02       Impact factor: 1.925

4.  Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats.

Authors:  Nicholas E Goeders; Glenn F Guerin
Journal:  Pharmacol Biochem Behav       Date:  2008-07-19       Impact factor: 3.533

5.  Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men.

Authors:  P Monteleone; M Maj; L Beinat; M Natale; D Kemali
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 6.  Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans.

Authors:  Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Clizia Zichi; Beatrice Fussotto; Roberta Giordano; Ezio Ghigo; Emanuela Arvat
Journal:  Endocrine       Date:  2012-07-27       Impact factor: 3.633

7.  The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.

Authors:  R Berardelli; I Karamouzis; V D'Angelo; B Fussotto; M A Minetto; E Ghigo; R Giordano; E Arvat
Journal:  J Endocrinol Invest       Date:  2015-10-08       Impact factor: 4.256

8.  Primary hyperaldosteronism is associated with derangement in the regulation of the hypothalamus-pituitary-adrenal axis in humans.

Authors:  R Giordano; M Pellegrino; A Picu; L Bonelli; S E Oleandri; C Pellissetto; P Limone; G Migliaretti; M Maccario; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.